These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16284190)

  • 1. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.
    Gutierrez A; Ratliff EP; Andres AM; Huang X; McKeehan WL; Davis RA
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):301-6. PubMed ID: 16284190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
    Shih DM; Kast-Woelbern HR; Wong J; Xia YR; Edwards PA; Lusis AJ
    J Lipid Res; 2006 Feb; 47(2):384-92. PubMed ID: 16269825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
    Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
    Song KH; Li T; Owsley E; Strom S; Chiang JY
    Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
    Bramlett KS; Yao S; Burris TP
    Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase.
    Miyake JH; Wang SL; Davis RA
    J Biol Chem; 2000 Jul; 275(29):21805-8. PubMed ID: 10823815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
    Al-Aqil FA; Monte MJ; Peleteiro-Vigil A; Briz O; Rosales R; González R; Aranda CJ; Ocón B; Uriarte I; de Medina FS; Martinez-Augustín O; Avila MA; Marín JJG; Romero MR
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2927-2937. PubMed ID: 29883717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids.
    Handschin C; Gnerre C; Fraser DJ; Martinez-Jimenez C; Jover R; Meyer UA
    Arch Biochem Biophys; 2005 Feb; 434(1):75-85. PubMed ID: 15629111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
    Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
    Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.
    Miyata M; Tanaka T; Takahashi K; Funaki A; Sugiura Y
    Amino Acids; 2021 Oct; 53(10):1523-1532. PubMed ID: 34596761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.
    Dawson PA
    Dig Dis; 2015; 33(3):382-7. PubMed ID: 26045273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.
    Shin DJ; Osborne TF
    J Biol Chem; 2009 Apr; 284(17):11110-20. PubMed ID: 19237543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.